Khatami Kiana, Estedlal AliReza, Vali Mohebat, Kamalipour AliReza, Mahmoudinezhad Golnoush, Nejabat Mahmood, Nowroozzadeh Mohammad Hossein, Vardanjani Hossein Molavi
MD-MPH Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Int Ophthalmol. 2023 Dec;43(12):4719-4728. doi: 10.1007/s10792-023-02872-2. Epub 2023 Sep 15.
The purpose of this study was to investigate the prevalence of cataracts, refractive disorders, age-related macular disease (AMD), and glaucoma, as well as their trends from 1990 to 2019 in Iran, in comparison with high-middle socio-demographic index (HMSDI) countries and the world, using the Global Burden of Disease (GBD) 2019 study.
The GBD study provided data on the prevalence of blindness and visual impairment (VI), as well as four of their causes including cataracts, refractive disorders, age-related macular disease (AMD), and glaucoma. Using Joinpoint analysis, the annual percent change (APC) was calculated to assess the trend of change in prevalence in each category of diseases from 1990 to 2019, stratified by sex and age, for Iran, HMSDI countries, and the world.
In 2019, refractive errors and cataracts were the most common causes of blindness and VI for both genders in Iran, HMSDI countries and the world. Iran had a higher age-standardized prevalence in all four categories of ophthalmologic disorders compared to HMSDI countries and the world for both genders in 2019. Additionally, the age-specific prevalence of all four disorders in 2019 was higher in Iran compared to HMSDI countries. However, in terms of trends of prevalence from 1990 to 2019, the rate of reduction for the four ophthalmologic disorders in Iran was higher than in HMSDI and the world for both males and females. Furthermore, Iran had a greater percentage of reduction in prevalence for all age groups in all four disorders compared to HMSDI countries.
The prevalence of cataracts, refractive errors, AMD, and glaucoma in Iran was higher compared to HMSDI countries in 2019 for both sexes and all age groups, but the trends of prevalence for all four disorders from 1990 to 2019 in Iran had a higher slope of reduction compared to HMSDI countries for all ages and sexes.
本研究旨在利用2019年全球疾病负担(GBD)研究,调查伊朗白内障、屈光不正、年龄相关性黄斑疾病(AMD)和青光眼的患病率及其在1990年至2019年期间的变化趋势,并与高中社会人口指数(HMSDI)国家及全球进行比较。
GBD研究提供了失明和视力损害(VI)患病率的数据,以及包括白内障、屈光不正、年龄相关性黄斑疾病(AMD)和青光眼在内的四种病因的数据。使用Joinpoint分析计算年度百分比变化(APC),以评估1990年至2019年期间伊朗、HMSDI国家和全球各类疾病患病率的变化趋势,按性别和年龄分层。
2019年,屈光不正和白内障是伊朗、HMSDI国家和全球男女失明和视力损害的最常见原因。2019年,伊朗在所有四类眼科疾病中的年龄标准化患病率均高于HMSDI国家和全球。此外,2019年伊朗所有四种疾病的年龄特异性患病率均高于HMSDI国家。然而,就1990年至2019年的患病率趋势而言,伊朗四种眼科疾病的患病率下降率高于HMSDI国家和全球的男性和女性。此外,与HMSDI国家相比,伊朗在所有四种疾病的所有年龄组中患病率下降的百分比更大。
2019年,伊朗白内障、屈光不正、AMD和青光眼的患病率在所有性别和年龄组中均高于HMSDI国家,但1990年至2019年期间伊朗所有四种疾病的患病率趋势与HMSDI国家相比,各年龄和性别的下降斜率更高。